Remepy raises $36M
Remepy announced a Series A round of $36M on 12 August 2026. The company operates in HealthTech and is based in United States. It was founded by Michal Tsur, Co-CEO.
Founder
Michal Tsur
Co-CEO, Remepy
Outreach angles
- -Michal Tsur, previously a co-founder of video platform Kaltura, now co-leads Remepy as Co-CEO alongside Or Shoval.
- -Tsur is applying her software background to combine prescription medicines with personalized AI-driven therapeutic apps.
- -The $36 million Series A funds Remepy's Hybridopa program as it enters Phase III trials for Parkinson's disease in the fourth quarter of 2026.
Signals
Series AHealthcareAI-NativeSecond-Time FounderDeep Tech
Round details
Company: Remepy
Domain: remepy.com
Amount: $36M
Stage: Series A
Industry: HealthTech
Country: United States
Announced: 12 August 2026
Other HealthTech raises
Recently funded in United States